Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea

Journal of Clinical Microbiology

Volumn 51, Issue 9, 2013, Pages 2884-2892

  Antharam, Vijay C ^a   Li, Eric C ^a   Ishmael, Arif ^a   Sharma, Anuj ^a   Mai, Volker ^b   Rand, Kenneth H ^a   Wang, Gary P ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

ADULT; ARTICLE; BACTERIAL GENOME; BACTERIUM IDENTIFICATION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; FECES ANALYSIS; FEMALE; FIRMICUTES; GENOME ANALYSIS; HOSPITAL INFECTION; HUMAN; INTESTINAL DYSBIOSIS; INTESTINE FLORA; INTESTINE INFECTION; LACHNOSPIRACEAE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PYROSEQUENCING; RUMINOCOCCACEAE; SEQUENCE ANALYSIS; SPECIES DIVERSITY; SPECIES RICHNESS;

ADULT; AGED; BACTERIA; BIOTA; BUTYRIC ACID; CLOSTRIDIUM INFECTIONS; CLUSTER ANALYSIS; CROSS INFECTION; DIARRHEA; DNA, BACTERIAL; DNA, RIBOSOMAL; DYSBIOSIS; FEMALE; GASTROINTESTINAL TRACT; HUMANS; MALE; METAGENOMICS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; UNITED STATES;

EID: 84882779621     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00845-13     Document Type: Article

References (43)

1. Ananthakrishnan AN. 2011. Clostridium difficile infection: epidemiology, risk factors and management. Nat. Rev. Gastroenterol. Hepatol. 8:17-26.
2. O'Keefe SJ. 2010. Tube feeding, the microbiota, and Clostridium difficile infection. World J. Gastroenterol. 16:139-142.
3. Parkes GC, Sanderson JD, Whelan K. 2009. The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea. Lancet Infect. Dis. 9:237-244.
4. Pepin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, Godin D, Bourassa C. 2005. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin. Infect. Dis. 40:1591-1597.
5. Petrella LA, Sambol SP, Cheknis A, Nagaro K, Kean Y, Sears PS, Babakhani F, Johnson S, Gerding DN. 2012. Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clin. Infect. Dis. 55:351-357.
6. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JF, Tijssen JG, Speelman P, Dijkgraaf MG, Keller JJ. 2013. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368:407-415.
7. Bakken JS. 2009. Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe 15:285-289.
8. Borody TJ. 2000. "Flora power": fecal bacteria cure chronic C. difficile diarrhea. Am. J. Gastroenterol. 95:3028-3029.
9. Brandt LJ, Aroniadis OC, Mellow M, Kanatzar A, Kelly C, Park T, Stollman N, Rohlke F, Surawicz C. 2012. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am. J. Gastroenterol. 107:1079-1087.
10. Famularo G, Trinchieri V, De Simone C. 2001. Fecal bacteriotherapy or probiotics for the treatment of intestinal diseases? Am. J. Gastroenterol. 96:2262-2264.
11. Russell G, Kaplan J, Ferraro M, Michelow IC. 2010. Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol. Pediatrics 126:e239-e242.
12. Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ. 2010. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J. Clin. Gastroenterol. 44:354-360.
13. Berg RD. 1996. The indigenous gastrointestinal microflora. Trends Microbiol. 4:430-435.
14. Young VB, Schmidt TM. 2008. Overview of the gastrointestinal microbiota. Adv. Exp. Med. Biol. 635:29-40.
15. Naaber P, Smidt I, Stsepetova J, Brilene T, Annuk H, Mikelsaar M. 2004. Inhibition of Clostridium difficile strains by intestinal Lactobacillus species. J. Med. Microbiol. 53:551-554.
16. Rolfe RD, Helebian S, Finegold SM. 1981. Bacterial interference between Clostridium difficile and normal fecal flora. J. Infect. Dis. 143:470-475.
17. Chang JY, Antonopoulos DA, Kalra A, Tonelli A, Khalife WT, Schmidt TM, Young VB. 2008. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J. Infect. Dis. 197:435-438.
18. Hopkins MJ, Macfarlane GT. 2002. Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J. Med. Microbiol. 51:448-454.
19. Rea MC, O'Sullivan O, Shanahan F, O'Toole PW, Stanton C, Ross RP, Hill C. 2012. Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota. J. Clin. Microbiol. 50:867-875.
20. Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C, Goulding D, Rad R, Schreiber F, Brandt C, Deakin LJ, Pickard DJ, Duncan SH, Flint HJ, Clark TG, Parkhill J, Dougan G. 2012. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 8:e1002995. doi:10.1371/journal.ppat. 1002995.
21. Reeves AE, Koenigsknecht MJ, Bergin IL, Young VB. 2012. Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae. Infect. Immun. 80:3786-3794.
22. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. 2007. The Human Microbiome Project. Nature 449:804-810.
23. Wu GD, Lewis JD, Hoffmann C, Chen YY, Knight R, Bittinger K, Hwang J, Chen J, Berkowsky R, Nessel L, Li H, Bushman FD. 2010. Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16S sequence tags. BMC Microbiol. 10:206. doi:10.1186/1471-2180-10-206.
24. Pruesse E, Quast C, Knittel K, Fuchs BM, Ludwig W, Peplies J, Glockner FO. 2007. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res. 35:7188-7196.
25. Huse SM, Dethlefsen L, Huber JA, Mark Welch D, Relman DA, Sogin ML. 2008. Exploring microbial diversity and taxonomy using SSU rRNA hypervariable tag sequencing. PLoS Genet. 4:e1000255. doi:10.1371 /journal.pgen.1000255.
26. Lozupone C, Lladser ME, Knights D, Stombaugh J, Knight R. 2011. UniFrac: an effective distance metric for microbial community comparison. ISME J. 5:169-172.
27. Pavlidis P, Noble WS. 2003. Matrix2png: a utility for visualizing matrix data. Bioinformatics 19:295-296.
28. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. 2011. Metagenomic biomarker discovery and explanation. Genome Biol. 12:R60. doi:10.1186/gb-2011-12-6-r60.
29. Claesson MJ, Cusack S, O'Sullivan O, Greene-Diniz R, de Weerd H, Flannery E, Marchesi JR, Falush D, Dinan T, Fitzgerald G, Stanton C, van Sinderen D, O'Connor M, Harnedy N, O'Connor K, Henry C, O'Mahony D, Fitzgerald AP, Shanahan F, Twomey C, Hill C, Ross RP, O'Toole PW. 2011. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc. Natl. Acad. Sci. U. S. A. 108(Suppl 1):4586-4591.
30. Johnson JL, Francis BS. 1975. Taxonomy of the Clostridia: ribosomal ribonucleic acid homologies among the species. J. Gen. Microbiol. 88: 229-244.
31. Collins MD, Lawson PA, Willems A, Cordoba JJ, Fernandez-Garayzabal J, Garcia P, Cai J, Hippe H, Farrow JA. 1994. The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. Int. J. Syst. Bacteriol. 44:812-826.
32. Shahinas D, Silverman M, Sittler T, Chiu C, Kim P, Allen-Vercoe E, Weese S, Wong A, Low DE, Pillai DR. 2012. Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing. mBio 3:e00338-12. doi:10 .1128/mBio.00338-12.
33. Hopkins MJ, Sharp R, Macfarlane GT. 2001. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 48:198-205.
34. Manges AR, Labbe A, Loo VG, Atherton JK, Behr MA, Masson L, Tellis PA, Brousseau R. 2010. Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridium difficileassociated disease. J. Infect. Dis. 202:1877-1884.
35. Peterfreund GL, Vandivier LE, Sinha R, Marozsan AJ, Olson WC, Zhu J, Bushman FD. 2012. Succession in the gut microbiome following antibiotic and antibody therapies for Clostridium difficile. PLoS One 7:e46966. doi:10.1371/journal.pone.0046966.
36. Cook SI, Sellin JH. 1998. Review article: short chain fatty acids in health and disease. Aliment. Pharmacol. Ther. 12:499-507.
37. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. 2006. Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol. 40:235-243.
38. Rolfe RD. 1984. Role of volatile fatty acids in colonization resistance to Clostridium difficile. Infect. Immun. 45:185-191.
39. Su WJ, Waechter MJ, Bourlioux P, Dolegeal M, Fourniat J, Mahuzier G. 1987. Role of volatile fatty acids in colonization resistance to Clostridium difficile in gnotobiotic mice. Infect. Immun. 55:1686-1691.
40. Borriello SP, Barclay FE. 1986. An in-vitro model of colonisation resistance to Clostridium difficile infection. J. Med. Microbiol. 21:299-309.
41. Reeves AE, Theriot CM, Bergin IL, Huffnagle GB, Schloss PD, Young VB. 2011. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile infection. Gut Microbes 2:145-158.
42. Goodman AL, Kallstrom G, Faith JJ, Reyes A, Moore A, Dantas G, Gordon JI. 2011. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc. Natl. Acad. Sci. U. S. A. 108:6252-6257.
43. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH. 2010. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect. Control Hosp. Epidemiol. 31:431-455.